Dr. Elahi and Mr. Bendaly contributed equally to this work.
Original Article
Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk
Article first published online: 1 JUL 2003
DOI: 10.1002/cncr.11587
Copyright © 2003 American Cancer Society
Additional Information
How to Cite
Elahi, A., Bendaly, J., Zheng, Z., Muscat, J. E., Richie, J. P., Schantz, S. P. and Lazarus, P. (2003), Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer, 98: 872–880. doi: 10.1002/cncr.11587
Publication History
- Issue published online: 1 AUG 2003
- Article first published online: 1 JUL 2003
- Manuscript Accepted: 19 MAY 2003
- Manuscript Revised: 13 MAY 2003
- Manuscript Received: 10 APR 2003
Funded by
- Public Health Service (PHS). Grant Numbers: DE12206, DE13158
- National Institutes of Health and Human Services. Grant Number: CA68384
- Abstract
- Article
- References
- Cited By
Keywords:
- oral carcinoma;
- UDP-glucuronosyltransferase;
- UGT1A10;
- tobacco carcinogenesis;
- polymorphism
Abstract
BACKGROUND
UGT1A10 exhibits glucuronidating activity against metabolites of the tobacco smoke carcinogen, benzo(a)pyrene, and is expressed highly in numerous target tissues for tobacco-related cancers including the upper aerodigestive tract. The current study was conducted to determine the prevalence of genetic polymorphisms in the UGT1A10-specific region of the UDP-glucuronosyltransferase family 1A locus and their relationship with risk for orolaryngeal carcinoma.
METHODS
The authors analyzed UGT1A10-specific sequences in a population of black, white, and Asian individuals. Ten UGT1A10 alleles were identified by direct sequencing of UGT1A10 sequences amplified by polymerase chain reaction (PCR) using DNA purified from buccal cell swabs that were taken from individual subjects.
RESULTS
In addition to three silent polymorphisms, three missense polymorphisms were found at codons 139 (Glu > Lys), 240 (Thr > Met), and 244 (Leu > Ile). Using PCR-restriction fragment length polymorphism analysis of buccal cell DNA, the prevalence of the UGT1A10240Met variant was less than 0.01% in whites and blacks. Similarly, the prevalence of both the UGT1A10139Lys and UGT1A10244Ile variants was less than 0.01% in whites but it was significantly higher (0.04 and 0.05, respectively, P < 0.01) in blacks. None of the missense UGT1A10 variants were found in any of the Asian individuals examined. In a case–control study of black individuals, a significant association with orolaryngeal carcinoma risk was found in persons with at least 1 UGT1A10139Lys allele (crude odds ratio, 0.29 [95% confidence interval, 0.10–0.81]; adjusted odds ratio, 0.20 [95% confidence interval, 0.05–0.87]). No association was observed for the codon 244 (Leu > Ile) polymorphism.
CONCLUSIONS
The data from the current study show that the UGT1A10 gene has several low-frequency missense polymorphisms and that the codon 139 polymorphism is an independent risk factor for orolaryngeal carcinoma in blacks. Cancer 2003;98:872–80. © 2003 American Cancer Society.
DOI 10.1002/cncr.11587

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)